arrow
A

Antonia Busse

charite - university medical center berlin
H指数:21
被引数:1,540

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial

CD19 CAR T细胞疗法治疗难治性血清阳性类风湿关节炎:一项1期临床试验

2026-08-270
PRE
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses

一种独特的CAR-T细胞表型介导了有限剂量下的治疗效果

2026-07-290
OA
Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome
2026-01-210
OAAI
CD22 Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignancies

CD22特异性T细胞受体使B细胞恶性肿瘤的过继性T细胞疗法成为可能。

Blood
IF23.1
2025-10-210
PRE
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer
2022-05-0240
OAAI
Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial
2022-02-0116
OAAI